Tag: Molecular Therapeutics
It was perseverance that directed Kirsten Bryant, PhD, to a discovery that ultimately led to plans for multiple clinical trials for pancreatic cancer, one of the deadliest cancer types. Bryant was recognized on Wednesday as one of three recipients of the Joseph S. Pagano Award, which recognizes outstanding work by the cancer center’s postdoctoral research … Continued
Once cancer treatment ends, hopefully with a clean bill of health, most patients hightail it away from the hospital, putting the endless batteries of tests, needle sticks and scans in their rearview mirror. So it’s a rare patient that returns of their own volition, and rarer still, becomes a lab volunteer. But that’s exactly what David Hesmer did.
Bryan L. Roth, MD, PhD, the Michael Hooker Distinguished Professor of Protein Therapeutics and Translational Proteomics in the Department of Pharmacology in the UNC School of Medicine, has been elected to the American Academy of Arts and Sciences. Roth, a member of the UNC Lineberger Comprehensive Cancer Center and the UNC Neuroscience Center, was one … Continued
University of North Carolina Lineberger Comprehensive Cancer Center researchers presented innovative new strategies for using tiny particles – particles the size of a DNA molecule or the width of a human hair – to boost cancer treatment as part of the Carolina Center of Cancer Nanotechnology Excellence/National Cancer Institute site visit on Tuesday. The researchers, … Continued
The American Institute for Medical and Biological Engineering (AIMBE) has inducted University of North Carolina Lineberger Comprehensive Cancer Center member Andrew Wang, MD, into its College of Fellows. Wang, an associate professor in the UNC School of Medicine Department of Radiation Oncology and director of clinical and translational research in the department, and 156 other … Continued